Tag Archives: algae oil

Source-Omega Validates Singapore Clinical Model for CereNate™ DHA 2012 Launch

Source-Omega today announced CereNate™ DHA is officially accepted for sale in Singapore.

Chapel Hill, NC (USA), Saturday – January 14, 2012 — Source-Omega today announced CereNate™ DHA is officially accepted for sale in Singapore. The validation is from the Health Sciences Authority (HSA) Singapore, registration number HPRG-HSU-2011-11-0030, in compliance with the Guidelines for Health Supplements.

CereNate DHA is made from an unblended GRAS registered algae oil omega-3 in an algae-based softgel. Novamed Singapore is the CereNate DHA importer. Novamed expects to establish immediate market share with OB/GYN doctors. CereNate DHA branding and licensing were previously announced in press on October 10th, 2011.

Source-Omega’s algae oil supply-chain has continuance confirmed. “We have two valid license agreements with our supplier, with continuance in supply under the new ownership,” said Dr Doughman.

Dr Doughman suggests successful products will naturally identify future opportunities in conventional markets, converting them into profitable models. CereNate DHA will be the first all-vegetarian DHA finished product in Singapore.

Source-Omega is a US-based manufacturer of vegetarian algae oil supplements, sourcing sustainable quality omega-3s from algae oil since 2007.

“Source-Omega has a proven track record of success working with companies interested in branding and launching omega-3 supplement products. We work with clients to help them analyze issues they might otherwise avoid or miss. The fun and exciting part is collaborating on a project with the end consumer in mind,” says Dr Doughman.

Source-Omega has expertise in manufacturing, molecular biology, lipid biochemistry, regulatory and compliance, human research ethics, pharmacology, scientific literature reviews, branding and other product developments.

About Source-Omega, LLC:
The privately held company is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the international marketplace for manufacturing, branding, private labeling and globalization of algae oil nutritional products.

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
P.O. Box 5208
Chapel Hill, NC 27516 – USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

Source-Omega Advocates Algae Oil for Diabetics in India, China and the USA in New Publication

Source-Omega, a finished products manufacturer and educational marketing company, announced today their new peer-reviewed publication titled “A Substitute for Fish Oil: Qualifying Algae Oil Omega-3s as a Medical Food,” written by Dr Scott D. Doughman, PhD, CEO and Chief Scientific Officer.

Chapel Hill, NC (USA), Friday – January 13, 2012 — The Source-Omega company’s invited manuscript was accepted after independent international peer review. It is published as an academic chapter in the book Environmental Pollution: Ecology and Human Health, published by Narosa (India) [http://www.narosa.com/books_display.asp?catgcode=978-81-8487-112-8].

Source-Omega maintains its R&D is always expanding and touts its public health research focus. They are seeking to identify the largest populations with the greatest omega-3 need.

Doughman’s collaborations with senior medical and scientific experts in India helped define trends in onset correlated with urbanization and modern dietary changes. He pointed out the greatest incidence of type-2-diabetes occurs in India, China and the USA, respectively (1).

Their report does not discuss relative rates of onset in these countries other than the fact that world diabetes onset is doubling every 30 years, with 200 million people worldwide diagnosed to have this largely preventable disease.

Doughman commented on the quality and safety of algae oil and the global diabetes need. “Based on a full survey of the evidence-based literature, there is a tremendous opportunity for more omega-3 research from university groups. We report how algae oil significantly and safely benefits diabetics with dyslipidemias and elevated postprandial triglycerides, without introducing any known glucose control side effects or drug interactions in this population,” he said.

Lead editor of the book compilation, Dr. Gottipolu R. Reddy, is Professor and Head, Division of Neuroscience, Department of Zoology, Sri Venkateswara University, Tirupati, India. Dr. Reddy is known internationally for his research in the area of developmental neurotoxicity of heavy metals. Dr. Reddy and Dr. Doughman met at a 2009 symposia at the historic Bangalore University, Department of Zoology, where each had been invited speakers.

High-DHA algae oil has no environmental pollutants, is natural cultured oil grown in enclosed controlled systems. The safety of high-DHA omega-3 algae oil intake by a type-2-diabetic was previously published on in review by Doughman et al., 2007 (2).

Other Source-Omega publications and articles in India on algae oil topics include peer reviewed manuscripts published in 2008 with the Indian Science Congress and in 2009 by the University of Madras, Department of Zoology. Recently Doughman’s Visiting Faculty work has been written about by the Asian Scientist (3,4,5).

The company suggested that future studies on environmental pollution-effects will likely show significant contributions to diabetes onset worldwide, but acknowledged that algae oil DHA can only address the chronic dietary component of the disease.

Doughman commented, “Progress is being made in educating about the two sides of the type-2-diabetes coin, sugar and fat, not just sugar.”

He then added, “We should not say the cause is the ‘Western diet’. Diabetes is increasing with convenience diets, affluence, urbanization and possibly pollution. To say Western diet invites cultural blame and most diabetics do not eat a Western diet, rather refined sugars, starches and oils all play contributing roles as added ingredients in processed foods made all around the world.”

Current science and consensus indicates eating fish is linked to lower blood glucose concentrations and the related associations to a reduced risk of developing diabetes, discovered as a result of the Prevention with a Mediterranean Diet study conducted by Mercedes Sotos Prieto in Spain through the University of Valencia. The study was conducted with the Valencia population involving 945 people (340 men and 605 women) between the ages of 55 to 80 who had high cardiovascular risk backgrounds.

Source-Omega is a member of the Global Organization for EPA and DHA Omega-3s (GOED), a trade group advocating for the ethical and sustainable use of omega-3 fatty acids in nutrition and medicine. GOED’s website [http://www.goedomega3.com] suggests omega-3 prevention measures worldwide could help save $47 trillion in chronic disease costs, including the long term complications and costs associated with the diabetes epidemic.

References:
(1) Doughman. A Substitute for Fish Oil: Qualifying Algae Oil Omega-3s as a Medical Food. (2011), in press, reprints available upon request.
(2) Doughman et al., Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev. (2007), 3:198-203
(3) http://sciencecongress.nic.in/html/pdf/Aug_Sept_2008.pdf
(4) http://www.envismadrasuniv.org/nl20094%20articles%20Medicinal%20and%20nutritional.htm
(5) http://www.asianscientist.com/topnews/sai-baba-studied-link-omega-3-fish-oils-type-2-diabetes/

Press & Media Contact;
Gene Wolf
Source-Omega, LLC
P.O. Box 5208
Chapel Hill, NC 27516 – USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

Martek Sale Spurs Investment and Sales Developments at Source-Omega

Source-Omega, LLC announces increased private investment in its growing business model since the Martek Biosciences Corporation sale in December 2010.

Chapel Hill, NC, February 26, 2011 — Source-Omega, LLC announces increased private investment in its growing business model since the Martek Biosciences Corporation sale in December 2010. The company references “weekly” corporate international demand for its Pure One™ algae oil product formulation using life’sDHA™, which the company also co-brands with Pure One™ for international private label contracts through Source-Omega. Also, the Source-Omega company’s expert pipeline in premium sourced omega-3 products gives Source-Omega solid positions in exports, contracting, branding and medical food.

“Ours is a values-based, educational marketing program with product development services. The Pure One branded innovations have truly advanced the depth of the entire omega-3 supplement trade. Our mission is to provide pure omega-3 innovations, access and solutions to all the world’s people,” said Scott Doughman, PhD, President and Chief Scientist at Source-Omega. Dr. Doughman added that Source-Omega had entered the algae oil supplement manufacturing market early and helped to drive collaborative product development innovations toward successful new quality standards with value added cultural significances.

Please contact Dr. Doughman for more information at info@source-omega.com. Ph: 919-360-5275; Web: http://www.source-omega.com

About Source-Omega:
Source-Omega, LLC is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the international marketplace for manufacturing, branding, private labeling and globalization of algae oil nutritional products under the name and formula Pure One™, the Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs, brain health, and for pregnancy, nursing and family care.

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

Pure One Next Gen Omega-3 Announces Optimized DHA3™ ForeBRAIN

Source-Omega, LLC announces Optimized DHA3™ ForeBRAIN(SM) as the second product in their line of Next Gen Plant Based Omega-3™ for premium optimized vegetarian lipids.

Chapel Hill, NC, February 25, 2011 — Source-Omega, LLC announces Optimized DHA3™ ForeBRAIN(SM) as the second product in their line of Next Gen Plant Based Omega-3™ for premium optimized vegetarian lipids. The product is planned for launch on Earth Day 2011.

Optimized DHA3™ ForeBRAIN(SM) contains select algae oil that is rich in DHA n-3 (300 mg) and DPA n-6 (100 mg) plus EPA n-3 (10 mg). Pure One™ DHA plus DPA n-6 and EPA furthers the company’s proprietary 300 mg DHA + 10 mg EPA formulation using algae oil.

The product will be 30 capsules for a one month supply. One capsule per day of the Pure One product is suggested to support brain structure and function in children 4 and over and in adults. Greater levels of DHA plus EPA are required to lower triglycerides for heart health in adults.

“We seek to most completely educate the consumer about how the new Pure One™ omega-3 product supports brain structure and function. The ForeBRAIN product is consistent with our prior observation that Pure One™ algae oil fatty acids are balanced to match the body’s needs. This means that the human brain make-up of omegas is more closely matched by the Pure One™ ForeBRAIN product ratios” said Scott Doughman, PhD, President and Chief Scientist at Source-Omega.

Since before the company was formed, Doughman started looking at how the human brain and organs are made up in terms of omega fatty acids. He said he observed parallels between ratios and levels of omega fats in eggs, breast milk and one algae oil strain in terms of the oil fat balance and the human brain fat composition.

The DPA n-6 lipid in ForeBRAIN comes from the same Non-GMO algae strain as the first Pure One product and is safe for pregnant and nursing mothers. The company stated that it has always known the DPA n-6 potential. Source-Omega is the first to distinguish their new 35 percent DHA plus about 15 percent DPA n-6 through the Pure One™ brand.

DHA AND DPA n-6
The human forebrain contains some of the highest levels of DHA in the brain. More is being discovered about the levels of DPA n-6 in the brain, yet no dietary recommendations are currently available. Many experts recommend DHA intake of at least 300 mg per day, but with little discussion of DPA n-6, a non-inflammatory structural lipid normally found in the brain, in human breast milk and in eggs.

The Pure One™ vegetarian form of the “egg lipids” DHA, DPA and EPA together may provide greater brain support than DHA alone, although literature research on the topic is very early. 100 mg DPA n-6 per serving is considered safe and beneficial as a fatty acid that is also present in the general food supply and is safe at higher dosages. The oil is GRAS and infant formula grade, kosher and pure.

“Optimized DHA3™ ForeBRAIN(SM) has emerged out of years of research. Our published review from 2007 discusses the range and ratio of DHA n-3 to DPA n-6 in human breast milk. Optimized DHA3™ ForeBRAIN features the median ratio of 3:1 DHA/DPA found in human breast milk [REF1],” said Doughman.

About Source-Omega:
Source-Omega, LLC is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the international marketplace for manufacturing, branding, private labeling and globalization of algae oil nutritional products under the name and formula Pure One™, the Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs, brain health, and for pregnancy, nursing and family care.

[REF1]: Doughman SD, Krupanidhi S, Sanjeevi CB. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev. 2007 3(3):198-203.

Press & Media Contact;
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

Source-Omega Joins GOED Committee and Features Pure One DHA + EPA Algae Oil

Source-Omega and its Pure One™ branded products are featured on the website of the Global Organization for EPA and DHA Omega-3s (GOED).

Chapel Hill, NC, February 24, 2011 — Source-Omega and its Pure One™ branded products are featured on the website of the Global Organization for EPA and DHA Omega-3s (GOED).

The company manufactures and markets Pure One™, the first and only US made Optimized Omega-3 DHA + EPA algae oil supplement formulation sold as a finished product. The Pure One™ omega-3 ratio is based on the science of human omega-3 metabolism.

The product range is kosher, vegan, infant formula grade and safe in all people, appropriate for those with type-2 diabetes, fish allergies, dietary restrictions and food sensitivities. Source-Omega uses only gluten-free, soy-free plant-based ingredients, all GMP processed in the USA.

The GOED Newsletter announced Source-Omega as the 108th member, with 5 new members listed after the First GOED Exchange in Salt Lake City, January 2011, attended by Source-Omega’s President and Chief Scientist, Dr Scott Doughman, PhD.

“Our product offerings are rapidly expanding the branded value of DHA+EPA from algae oil for international products,” said Doughman.

The importance of DHA and EPA are well established and partly informed by the new Dietary Guidelines for Americans (DGA), which suggests “fortified foods and dietary supplements may be useful in providing one or more nutrients that otherwise may be consumed in less than recommend amounts.”

Government bodies like the Food and Drug Administration (FDA) and the American Heart Association (AHA) recognize the qualified use of DHA and EPA recommendations.

Source-Omega’s qualified products meet GOED’s Monogram and strict ethics, which lend industry recognized credentials to the Pure One product.

“The Source-Omega company has made substantial contributions to the industry in only 3 years, plus our beautiful golden omega-3 oil is a leading international brand that drives awareness of pure algae oil for both DHA and EPA from one strain, Pure One, made without any chemical modifications for our differentiated, premium diabetic-friendly, nutraceutical supplement,” said Dr Doughman, who brought the Pure One™ branded innovations to the public in early 2008.

Source-Omega offers private labeling internationally in liquid oil, dietary supplements and medical food. Source-Omega’s plant-based algae omega-3 DHA + EPA products were first formulated by Dr. Scott Doughman in early 2007 while engaged in Omega-3 research at the University of North Carolina’s School of Public Health, funded by the National Institutes of Health.

Source-Omega is located in Chapel Hill, North Carolina, in historic Chatham County, and offers its patent pending omega-3 products made using an advanced vegetarian softgel technology combined with select algae oil grown in the USA.

Press & Media Contact;
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

Source-Omega Seeks $5 Million for India OMEDHA Study of DHA-Rich Algae Oil

OMEDHA™, a Medical Food for Postprandial Triglyceride Testing in Diabetics. Algae oil is the purest and safest DHA+EPA bioscience resource known, one that India needs,” said Filippo Porco, an International Communication Specialist with Source-Omega.

Chapel Hill, NC, January 13, 2011 — The Source-Omega company is an innovator in DHA+EPA algae oil products for heart and triglyceride applications, also in NIDDM patients. The company’s first offering, Pure One™, features their flagship international formula and brand, manufactured to international standards for quality, cultural and dietary inclusion. OMEDHA(TM) is planned and formulated for Indian markets.

The Source-Omega company’s second branded offering, OMEDHA™, is based on 3 years of dose-response research and a recently submitted manuscript review on the Indian diabetes dilemma and uses of algae oil omega-3s as a superior postrandial triglyceride treatment over fish oils, especially in a vegetarian and a patient with fish allergy.

Also, an academic book chapter on their algae oil medical food substitute for fish oil was accepted for 2011 publication in India. Dr Scott Doughman, the company President and Chief Scientist will be traveling to India in February this year as a 10 year Visiting Faculty in Biosciences at the internationally renowned Sai University (SSSIHL).

“OMEDHA™ is the branded form of our Omega-3 DHA Therapy™, offered in the USA for several years to vegetarian’s with high triglycerides, backed by a large and growing body of literature in humans,” said Doughman, who has a PhD in Lipid Biochemistry, a former NIH funded omega-3 researcher and American Heart Association fellow.

Doughman developed the product formulation 300 mg DHA + 10 mg EPA, balanced to match the body’s omega-3 needs, as the first disclosed algae oil DHA+EPA made in the USA, launched in early 2008.

For More information please contact 919-360-5275; info@source-omega.com; http://www.source-omega.com

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

DHA is for Lowering Triglycerides Naturally: Source-Omega Praises EFSA Judgment

An internal Source-Omega report suggests at 3 months, high triglyceride reductions with DHA are temporally correlated with omega-3 essentiality, or saturation levels of omega-3s in red blood cell (RBC) membranes, also called the omega-3 index.

Chapel Hill, NC, November 29, 2010 — An interview this week with Baldur Hjaltason, chairman of leading marine-sourced omega-3 group the Global Organization for EPA and DHA Omega-3 (GOED), and strategic business development manager at EPAX, and Adam Ismail, GOED executive director. On November 23, 2010, when asked by Nutraingredients reporter Shane Starling about the 2.0 g DHA claim for triglycerides management, Baldur Hjaltason said, “The omega-3 industry has been driven by solid science. That is the reason we are seeing so many approved claims, because we have such a great amount of scientific data to support those claims.”

The long-chain omega-3 fatty acid docosahexaenoic acid (DHA; 22:6 n-3) comprises over 80 percent of the omega-3 composition in the human body. This fact has not escaped non-fish-based advocates of algae oil DHA treatments for high triglycerides. The literature shows over 16 studies of algae oil DHA supplements providing significant improvements in hypertrygliceridemia (HTG), commonly known as high triglyceride levels above 200 mg/dl triglycerides in plasma in a fasting state.

Since high triglycerides are commonly found in type 2 diabetes subjects, Source-Omega ( http://www.source-omega.com ) recently conducted a study of the mechanisms and evidence for how DHA might protect against diabetic etiologies affected by high triglycerides. “We observed that DHA-rich microalgae oil is more effective than fish oil mixtures low in DHA at lowering high postprandial triglyceride levels,” said Scott Doughman, Ph.D., Chief Scientist at Source-Omega.

Source-Omega has also been looking at the need in Asian Indian urban populations particularly at risk for HTG and diabetes onset due to factors such as urbanization, dietary changes and genetic factors inherent to the traditionally non-fish-eating population.

Source-Omega’s Report Findings:

1) Clinical studies in the United States and elsewhere show DHA from microalgae oil targets HTG.

2) At 3 months, the HTG reductions with DHA are temporally correlated with omega-3 essentiality, or saturation levels of omega-3s in red blood cell (RBC) membranes, also called the omega-3 index.

3) DHA reduces triglyceride levels over 25 percent when taken at levels greater than 1000 mg daily for 3 months, doubling total omega-3 levels.

4) 1200 mg DHA per day gives about 1000 mg bioavailable DHA.

5) DHA is the major omega-3 present in neuroendocrine beta-cell membranes and in immunological cells.

6) While microalgae oil DHA studies have not been performed using insulin producing cells, fish oil studies clearly show DHA is the only accretive omega-3 in pancreatic beta-cell membranes.

7) While DHA does not affect glucose homeostasis in diabetic subjects, increases in DHA levels over time correlated with improvements in insulin secretion and insulin function, suggesting beta-cell dependent and independent mechanisms.

8) The utility of 1200 mg DHA as an optimized dosage for the reduction of moderately high HTG and a low plasma omega-3 index for optimizing health status was supported by several independent studies as a near-maximal metabolic dose for greatest results per dose.

About Source-Omega, LLC:
Located in Chapel Hill North Carolina, founded in 2007, Source-Omega developed the Pure One™ Formula out of the published academic work and innovations of Scott Doughman, Ph.D., Lipid Biochemist and a former National Institutes of Health funded omega-3 researcher, previously also an American Heart Association fellow with over 12 years of lipid research experience. Since 2007, the company has rapidly grown with a focus on high triglycerides and their Omega-3 DHA Therapy™ for results oriented omega-3 dosages. The product stability, ecological sustainability, vegan and Kosher registrations and research behind Pure One™, each lend qualifications that provide value added advantages. The Pure One™ Brand and Formula are available for licensing from Source-Omega.

Press & Media Contact:
Scott D. Doughman, PhD
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

NC Company Partnering with South Africa Company to Offer Medical Food Product Internationally

Source-Omega licenses Solal Technologies of Johannesburg, South Africa, to offer novel Vegetarian Omega-3 (SM) product with DHA and EPA from sustainable algae oil source.

Chapel Hill, NC, November 24, 2010 — Source-Omega, LLC ( http://www.source-omega.com ) is now offering private labeling of its vegetarian algae oil in international markets.

The company has licensed Solal Technologies of Johannesburg, South Africa, to offer Vegetarian Omega-3 (SM).

“Solal is an ideal business partner for Source-Omega,” said Dr. Scott Doughman, president and founder of Source-Omega. “Both companies have the same goal, offering a product that fills an important need not met with modern diets and lifestyle.”

The oil has been licensed for sale in the South African pharmaceutical market under a “medical food” label licensed to Solal under the Pure One™ brand.

“Medical food” is a relatively new category established in the 1988 amendments to the Orphan Drug Act. The U.S. Food and Drug Administration requires that “medical foods” contain only ingredients classified as Generally Regarded as Safe (GRAS). Algae oil omega-3, which is entirely plant-based, meets this standard, however the Pure One™ label in the U.S. and South Africa are designated Dietary Supplements and are not a drug.

Solal will offer Vegetarian Omega-3 in pharmacies, behind the counter, as recommended by physicians for management of a low omega-3 index and high triglyceride levels. It will also be offered as an anti-aging non-prescription supplement. Vegetarian Omega-3 will be available directly to patients, through retail pharmacies, physicians and health stores based in South Africa.

“We are pleased to have this relationship with Source-Omega to offer a product that is so important to maintaining health,” said Colin Levin, a vegetarian and a director of Solal. “This will be a win-win-win, for Solal, Source-Omega, and, most importantly, for our patients and customers.”

Source-Omega is also working on expanding its markets through other private labeling arrangements outside the United States.

The basis of the oil is Source-Omega’s patent-pending formula of DHA and EPA for cardiovascular, metabolic and cognitive health management, offered in supplements and medical food. Pure One™ offers optimized omega-3 dosages and clinically proven triglyceride lowering benefits with documented results.

Certain omega-3 dosages have been proven effective for management of plasma lipids. As a medical food, it can fulfill the omega-3 requirements associated with DHA and EPA deficiencies in vegetarians, people who cannot eat fish, and those with special dietary needs not met by omega-3 seed sources such as flax oil. Vegetarian Omega-3(SM) is offered in a soft carrageenan capsule.

About Solal Technologies (Pty) Ltd: Located in Johannesburg, Solal Technologies works and supplies online to physicians, pharmacies and other outlets based in South Africa. Other divisions of Solal include The Compounding Pharmacy of South Africa, an Integrative Medical Center and a Health Intelligence magazine covering the science of health. For more information please visit http://www.solaltech.com

About Source-Omega, LLC:
Located in Chapel Hill North Carolina, founded in 2007, Source-Omega developed the Pure One™ Formula out of the published academic work and innovations of Scott Doughman, Ph.D., Lipid Biochemist and a former National Institutes of Health funded omega-3 researcher, previously also an American Heart Association fellow with over 12 years of lipid research experience. Since 2007, the company has rapidly grown with a focus on high triglycerides and their Omega-3 DHA Therapy™ for results oriented omega-3 dosages. The product stability, ecological sustainability, vegan and Kosher registrations and research behind Pure One™, each lend qualifications that provide value added advantages. The Pure One™ Brand and Formula are available for licensing from Source-Omega, LLC under their field of use and US patent application number 12/727,006 filed with the US Trademark and Patent Office, March 18th, 2010.

For more information please visit http://www.source-omega.com.

Press & Media Contact:
Scott D. Doughman, PhD
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

Source-Omega, a Manufacturer of Algae Oil Nutritional Products, Has Licensed Return 2 Health as a Distributor in New Zealand

Source-Omega offers its distributors not only a high-quality health product, but international branding and expertise in exporting and supply chain solutions.

Chapel Hill, NC, November 12, 2010 — Return 2 Health has an on-line store for products related to health and well-being, and it also serves naturopaths.

Source-Omega offers its distributors expertise. “We provide a well-managed partnership to our distributors,” said Scott Doughman, Ph.D., president of Source-Omega. “Distributors especially appreciate our product quality and supply chain security.”

Vegetarian omega-3 oils with both DHA and EPA are marketed by Source-Omega ( http://www.source-omega.com ) in the United States under the Pure One™ brand. Source-Omega’s oils come from sources approved by both the U.S. Food and Drug Administration and the European Commission.

Concern for quality led Return 2 Health to add Source-Omega ( http://www.source-omega.com ) products to its offerings.

“Our product lines are from brands you can trust and are of the highest pharmaceutical grade – formulated to provide safe, quality health supplements,” said Martin Thompson, Managing Director.

Source-Omega ( http://www.source-omega.com ) is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the manufacturing, branding, private labeling and globalization of algae oil nutritional products under the name Pure One™, Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs and for pregnancy, nursing and family care.

Return 2 Health was founded in 2003 and is based in Aukland. It specializes in natural health remedies.

For more information about Source-Omega, call 919-360-5275, or visit http://www.source-omega.com, or http://www.pureone-dha.com

For more information about Return 2 Health, visit http://www.return2health.net.

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com

Source-Omega Reviews DHA Retroconversion Metabolic Dosing Using Algae Oil Omega-3s as a Fish Oil Substitute

“What all the human omega-3 red blood cell data independently points out is that DHA is always 3 to 8 fold more abundant than EPA in human blood and tissues, even after prolonged intake of high doses of omega-3s predominantly as EPA,” says company scientist.

Chapel Hill, NC, November 11, 2010 — Today, Source-Omega ( http://www.source-omega.com ) revealed knowledge gained from their review of the omega-3 literature and published research. “What all the human omega-3 Red Blood Cell data independently point out is that DHA is always 3 to 8 fold more abundant than EPA in human blood and tissues, even after prolonged intake of high doses of omega-3s predominantly as EPA,” says Scott Doughman, PhD., Chief Scientist at Source-Omega.

Source-Omega revealed their discussion, forwarding that composition studies in 1978 proved DHA is naturally the most abundant omega-3 form in the human body and blood in comparison to EPA levels in untreated individuals (Sanders et al., 1978). In 1986, a review by Herold and Kinsella of human volunteers treated with fish oil omega-3s revealed higher DHA fatty acid composition in red blood cells compared to EPA, despite high EPA intake (Herold and Kinsella, 1986).

Fish oils have been an abundant source of EPA, so fewer studies may have taken into consideration that DHA is the most abundant omega-3 long chain fatty acid because EPA was the main omega-3 given as a fish oil treatment.

When Conquer and Holub published on algae oil DHA treatment of human subjects in 1996, a detailed double-blind randomized placebo controlled study, the authors found blood omega-3 parameters consistent with humans taking high dosages of fish oil (Conquer and Holub, 1996). The 1996 study showed RBC increases in both DHA and EPA through accretion of DHA and retroconversion of DHA. Other metabolism studies have shown DHA is also a template that will provide all the C22, C20, and C18 omega-3s needed in the body through retroconversion, say Source-Omega scientists.

DHA delivers saturation levels of omega-3s to RBC membranes when the DHA dosage ( http://www.source-omega.com ) for adult clinical use begins with 1.0 g to 1.2 g DHA per day, which company results, or previous published studies show can provide saturation levels of omega-3s within 90 days (Arterburn et al., 2008).

The scientific literature shows high-dose DHA derived from microalgae lowers hypertriglyceridemia after 90 days of treatment, by up to 26 percent with at least 1 g DHA daily (reviewed by Ryan et al., 2009). With a safe, effective dosage range for any adult, the GRAS safety registration of algae oil and the dosage range have been positively ruled-upon, as such, by several international regulatory bodies.

“The summary of these historical studies together suggest ‘directional omega-3 metabolism‘, where fish oil is ‘uphill’ and algae oil is ‘downhill’. EPA intake leads to multistep synthesis to DHA with fish oil. DHA intake leads to a single step retroconversion to EPA with algae oil. The body knows how to balance its final levels from each direction, but ‘downhill’ appears more efficient at high omega-3 doses,” said Doughman.

Each method then flows towards a somewhat pre-defined homeostatic balance of cellular and tissue specific omega-3 compositions, the data suggest.

Since the DHA retroconvertion dosing strategy is the opposite of fish oil, Source-Omega’s ( http://www.source-omega.com ) patent pending claims are on the dosage use and method of 1200 mg DHA + 40 mg EPA per day as metabolically ideal for certain health claims and postprandial triglyceride lowering benefits [References Available upon request from Source-Omega].

About Source-Omega:
Source-Omega, LLC is headquartered in Chapel Hill, North Carolina, near the Research Triangle Park. It was founded in 2007 and specializes in the international marketplace for manufacturing, branding, private labeling and globalization of algae oil nutritional products under the name and formula Pure One™, the Next Generation Plant Based Omega-3™ for their Omega-3 DHA Therapy™, for clinics offering triglyceride lowering plasma lipids management programs and for pregnancy, nursing and family care.

Press & Media Contact:
Gene Wolf
Source-Omega, LLC
52 Norwood Rd
Chapel Hill, NC 27516 USA
919-360-5275
info@source-omega.com
http://www.source-omega.com